Abstract
Radiation therapy is an effective means of achieving local control in a wide range of primary tumours, with the reduction in the size of the tumour(s) thought to mediate the observed reductions in metastatic spread in clinical trials. However, there is evidence to suggest that the complex changes induced by radiation in the tumour environment can also present metastatic risks that may counteract the long-term efficacy of the treatment. More than 25 years ago, several largely theoretical mechanisms by which radiation exposure might increase metastatic risk were postulated. These include the direct release of tumour cells into the circulation, systemic effects of tumour and normal tissue irradiation and radiation-induced changes in tumour cell phenotype. Here, we review the data that has since emerged to either support or refute these putative mechanisms focusing on how the unique radiobiology underlying modern radiotherapy modalities might alter these risks.
Similar content being viewed by others
Abbreviations
- CTC:
-
Circulating tumour cell
- NSCLC:
-
Non-small cell lung cancer
- 3D-CRT:
-
3D-conformal radiotherapy
- IMRT:
-
Intensity-modulated radiotherapy
- VMAT:
-
Volumetric modulated arc therapy
- FFF:
-
Flattening filter-free
- MRT:
-
Microbeam radiotherapy
- TGF-β:
-
Transforming growth factor-β1
- MMP:
-
Matrix metallo-proteinase
- EMT:
-
Epithelial-to-mesenchymal transition
References
Kaplan HS, Mury ED (1949) The effect of local roentgen irradiation on the biological behavior of a transplantable mouse carcinoma; increased frequency of pulmonary metastasis. J Natl Cancer Inst 9(5–6):407–413
Ebos J (2015) Prodding the beast: assessing the impact of treatment-induced metastasis. Can Res 75(17):3427–3435. https://doi.org/10.1158/0008-5472.CAN-15-0308
von Essen CF (1991) Radiation enhancement of metastasis: a review. Clin Exp Metast 9(2):77–104
Martin OA, Anderson RL, Russell PA, Cox AR, Ivashkevich A, Swierczak A, Doherty JP, Jacobs D, Smith J, Siva S, Daly PE, Ball DL, Martin RF, MacManus MP (2014) Mobilization of viable tumor cells into the circulation during radiation therapy. Int J Radiat Oncol Biol Phys 88(2):395–403. https://doi.org/10.1016/j.ijrobp.2013.10.033
Martin OA, Anderson RL, Narayan K, MacManus MP (2017) Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?. Nat Rev Clin Oncol 14:32–44
Baskar R, Lee K, Yeo R, Yeoh K-W (2012) Cancer and radiation therapy: current advances and future directions. Int J Med Sci 9(3):193–199. https://doi.org/10.7150/ijms.3635
Bucci KM, Bevan A, Roach M (2005) Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin 55(2):117–134. https://doi.org/10.3322/canjclin.55.2.117
Allison RR, Patel RM, McLawhorn RA (2014) Radiation oncology: physics advances that minimize morbidity. Future Oncol 10(15):2329–2344. https://doi.org/10.2217/fon.14.176
Murray LJ, Thompson CM, Lilley J, Cosgrove V, Franks K, Sebag-Montefiore D, Henry AM (2015) Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy. Phys Med Biol 60(3):1237–1257. https://doi.org/10.1088/0031-9155/60/3/1237
Irazola L, Ortiz-Seidel M, Velázquez S, García-Hernández M, Terrón J, Sánchez-Nieto B, Romero-Expósito M, Roselló J, Sánchez-Doblado F (2016) EP-1613: Comparison of peripheral doses associated to SBRT, VMAT, IMRT, FFF and 3D-CRT plans for lung cancer. Radiother Oncol 119. https://doi.org/10.1016/s0167-8140(16)32864-x
Hall EJ, Wuu C-S (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Rad Oncol Biol Phys 56(1):83–88. https://doi.org/10.1016/S0360-3016(03)00073-7
Lievens Y, Nulens A, Gaber M, Defraene G, Wever W, Stroobants S, den Heuvel F, Group L (2011) Intensity-modulated radiotherapy for locally advanced non–small-cell lung cancer: a dose-escalation planning study. Int J Rad Oncol Biol Phys 80(1):306–313. https://doi.org/10.1016/j.ijrobp.2010.06.025
Guckenberger M, Kavanagh A, Partridge M (2012) Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer. Strahlenther Onkol 188(10):894–900. https://doi.org/10.1007/s00066-012-0161-9
Chang AJ, Bradley JD (2010) Clinical perspectives on dose escalation for non–small-cell lung cancer. Clin Lung Cancer 11(5):299–302. doi:https://doi.org/10.3816/clc.2010.n.037
Murray D, McBride WH, Schwartz JL (2014) Radiation biology in the context of changing patterns of radiotherapy. Radiat Res 182(3):259–272. doi:https://doi.org/10.1667/RR13740.1
Hall EJ, Giaccia AJ (2012) Radiobiology for the radiologist, 7th edn. Wolters Kluwer Health, Philadelphia
Coutard H (1934) Principles of x ray therapy of malignant diseases. Lancet 224 (5784):1–8. https://doi.org/10.1016/S0140-6736(00)90085-0
Nahum AE (2015) The radiobiology of hypofractionation. Clin Oncol 27(5):260–269. https://doi.org/10.1016/j.clon.2015.02.001
Fowler JF, Welsh JS, Howard SP (2004) Loss of biological effect in prolonged fraction delivery. Int J Rad Oncol Biol Phys 59(1):242–249. https://doi.org/10.1016/j.ijrobp.2004.01.004
Joiner MC, Mogili N, Marples B, Burmeister J (2010) Significant dose can be lost by extended delivery times in IMRT with X rays but not high-LET radiations. Med Phys 37(6):2457–2465. https://doi.org/10.1118/1.3425792
Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Evensen J, Mortensen HR, Overgaard J (2015) The DAHANCA 6 randomized trial: effect of 6 vs. 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma. Radiother Oncol 117(1):91–98. https://doi.org/10.1016/j.radonc.2015.07.004
Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Palmar M (1999) Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steer Comm Radiother Oncol 52(2):137–148
Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M (1997) Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steer Comm Lancet 350(9072):161–165
Thomas EM, Popple RA, Prendergast BM, Clark GM, Dobelbower MC, Fiveash JB (2013) Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiency. J Appl Clin Med Phys 14(6):155–166. https://doi.org/10.1120/jacmp.v14i6.4328
Spratt DE, Wu AJ, Adeseye V, Din SU, Shaikh F, Woo KM, Zhang Z, Foster A, Rosenzweig KE, Gewanter R, Huang J, Rimner A (2016) Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non–small-cell lung cancer: implications for surveillance. Clin Lung Cancer 17(3):177–18300. https://doi.org/10.1016/j.cllc.2015.09.006
Verstegen NE, Lagerwaard FJ, Hashemi S, Dahele M, Slotman BJ, Senan S (2015) Patterns of disease recurrence after SABR for early stage non–small-cell lung cancer: optimizing follow-up schedules for salvage therapy. J Thorac Oncol 10(8):1195–1200. https://doi.org/10.1097/jto.0000000000000576
van den Berg LL, Klinkenberg TJ, Groen H, Widder J (2015) Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC. J Thorac Oncol 10(5):826–831. https://doi.org/10.1097/jto.0000000000000483
Kim M-S, Kim W, Park I, Kim H, Lee E, Jung J-H, Cho L, Song CW (2015) Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery. Radiat Oncol J 33(4):265–275. https://doi.org/10.3857/roj.2015.33.4.265
Brown MJ, Carlson DJ, Brenner DJ (2014) The tumor radiobiology of SRS and SBRT: are more than the 5 rs involved? Int J Radiat Oncol Biol Phys 88(2):254–262. https://doi.org/10.1016/j.ijrobp.2013.07.022
Shuryak I, Carlson DJ, Brown MJ, Brenner DJ (2015) High-dose and fractionation effects in stereotactic radiation therapy: analysis of tumor control data from 2965 patients. Radiother Oncol 115(3):327–334. https://doi.org/10.1016/j.radonc.2015.05.013
Girdhani S, Sachs R, Hlatky L (2013) Biological effects of proton radiation: what we know and don’t know. Radiat Res 181(6):257–272. doi:https://doi.org/10.1667/RR2839.1
Durante M, Orecchia R, Loeffler JS (2017) Charged-particle therapy in cancer: clinical uses and future perspectives. Nat Rev Clin Oncol. https://doi.org/10.1038/nrclinonc.2017.30
Paganetti H (2014) Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol 59 (22). https://doi.org/10.1088/0031-9155/59/22/R419
Hamada N, Imaoka T, Masunaga S-i, Ogata T, Okayasu R, Takahashi A, Kato TA, Kobayashi Y, Ohnishi T, Ono K, Shimada Y, Teshima T (2010) Recent advances in the biology of heavy-ion cancer therapy. J Radiat Res 51(4):365–383
Yoshioka Y, Suzuki O, Otani Y, Yoshida K, Nose T, Ogawa K (2014) High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective. J Contemp Brachyther 6(1):91–98. https://doi.org/10.5114/jcb.2014.42026
Lohse I, Lang S, Hrbacek J, Scheidegger S, Bodis S, Macedo NS, Feng J, Lütolf UM, Zaugg K (2011) Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiother Oncol 101(1):226–232. https://doi.org/10.1016/j.radonc.2011.05.072
Michaelidesová A, Vachelová J, Puchalska M, Brabcová K, Vondráček V, Sihver L, Davídková M (2017) Relative biological effectiveness in a proton spread-out Bragg peak formed by pencil beam scanning mode. Australas Phys Eng Sci Med. https://doi.org/10.1007/s13246-017-0540-8
Schüler E, Trovati S, King G, Lartey F, Rafat M, Villegas M, Praxel JA, Loo BW, Maxim PG (2017) Experimental platform for ultra-high dose rate FLASH irradiation of small animals using a clinical linear accelerator. Int J Radiat Oncol Biol Phys 97(1):195–203. https://doi.org/10.1016/j.ijrobp.2016.09.018
Bouchet A, Lemasson B, Duc G, Maisin C, Bräuer-Krisch E, Siegbahn E, Renaud L, Khalil E, Rémy C, Poillot C, Bravin A, Laissue JA, Barbier EL, Serduc R (2010) Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks. Int J Radiat Oncol Biol Phys 78(5):1503–1512. https://doi.org/10.1016/j.ijrobp.2010.06.021
Régnard P, Bräuer-Krisch E, Troprès I, Keyriläinen J, Bravin A, Duc G (2008) Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2008.04.049
Smyth LML, Senthi S, Crosbie JC, Rogers PAW (2016) The normal tissue effects of microbeam radiotherapy: what do we know, and what do we need to know to plan a human clinical trial? Int J Radiat Biol 92(6):302–311. https://doi.org/10.3109/09553002.2016.1154217
Rud A, Boye K, Fodstad Ø, Juell S, Jørgensen LH, Solberg S, Helland Å, Brustugun O, Mælandsmo G (2016) Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer. Diagn Pathol 11(1):50. https://doi.org/10.1186/s13000-016-0504-4
Maruyama R, Sugio K, Mitsudomi T, Saitoh G, Ishida T, Sugimachi K (1997) Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 114(4):535–543. https://doi.org/10.1016/S0022-5223(97)70041-2
Osaki T, Oyama T, Gu C-D, Yamashita T, So T, Takenoyama M, Sugio K, Yasumoto K (2002) Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol 20(13):2930–2936. https://doi.org/10.1200/jco.2002.11.011
Bouchard G, Therriault H, Bujold R, Saucier C, Paquette B (2017) Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development. Int J Radiat Biol. https://doi.org/10.1080/09553002.2017.1270471
Woods GM, Bondra K, Chronowski C, Leasure J, Singh M, Hensley L, Cripe TP, Chakravarti A, Houghton PJ (2015) Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma. Pediatr Blood Cancer 62(9):1550–1554. https://doi.org/10.1002/pbc.25516
Janni WJ, Rack B, Terstappen L, Pierga J-Y, Taran F-A, Fehm T, Hall C, de Groot MR, Bidard F-C, Friedl T, Fasching PA, Brucker SY, Pantel K, Lucci A (2016) Pooled analysis of the prognostic relevance of circulating tumor cells in primary breast cancer. Clin Cancer Res 22(10):2583–2593. https://doi.org/10.1158/1078-0432.CCR-15-1603
Suesskind D, Ulmer A, Schiebel U, Fierlbeck G, Spitzer B, Spitzer MS, Bartz-Schmidt KU, Grisanti S (2011) Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study. Acta Ophthalmol 89(1):17–24. https://doi.org/10.1111/j.1755-3768.2009.01617.x
Yu N, Zhou J, Cui F, Tang X (2015) Circulating tumor cells in lung cancer: detection methods and clinical applications. Lung. https://doi.org/10.1007/s00408-015-9697-7
Dorsey JF, Kao GD, MacArthur KM, Ju M, Steinmetz D, Wileyto PE, Simone CB, Hahn SM (2015) Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non–small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results. Cancer 121(1):139–149. https://doi.org/10.1002/cncr.28975
Masunaga S, Matsumoto Y, Kashino G, Hirayama R, Liu Y, Tanaka H, Sakurai Y, Suzuki M, Kinashi Y, Maruhashi A, Ono K (2010) Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations. Br J Radiol 83(993):776–784. https://doi.org/10.1259/bjr/57015642
Zhang Z, Wodzak M, Belzile O, Zhou H, Sishc B, Yan H, Stojadinovic S, Mason RP, Brekken RA, Chopra R, Story MD, Timmerman R, Saha D (2016) Effective rat lung tumor model for stereotactic body radiation therapy. Radiat Res 185(6):616–622. doi:https://doi.org/10.1667/RR14382.1
Tharmalingham H, Hoskin PJ (2017) The changing role of radiation therapy in the management of oligometastatic disease. Tech Innov Patient Support Radiat Oncol 1:13–15. https://doi.org/10.1016/j.tipsro.2017.01.001
Blyth BJ, Sykes PJ (2011) Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures? Radiat Res 181(6):139–157. https://doi.org/10.1667/rr2548.1
Sprung CN, Ivashkevich A, Forrester HB, Redon CE, Georgakilas A, Martin OA (2015) Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects. Cancer Lett 356(1):72–81. https://doi.org/10.1016/j.canlet.2013.09.008
Hong M (2014) Heavy ion-related bystander effects. Rend Lincei. https://doi.org/10.1007/s12210-013-0285-6
Revesz L (1958) Effect of lethally damaged tumor cells upon the development of admixed viable cells. J Natl Cancer Inst 20(6):1157–1186
van den Brenk HA, Crowe MC, Stone MG (1977) Reactions of the tumour bed to lethally irradiated tumour cells, and the Révész effect. Br J Cancer 36(1):94–104. https://doi.org/10.1038/bjc.1977.159
Kuonen F, Secondini C, Rüegg C (2012) Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment. Clin Cancer Res 18(19):5196–5202. https://doi.org/10.1158/1078-0432.ccr-11-1758
Rüegg C, Monnier Y, Kuonen F, Imaizumi N (2011) Radiation-induced modifications of the tumor microenvironment promote metastasis. Bull Cancer 98(6):47–57. https://doi.org/10.1684/bdc.2011.1372
Vala I, Martins LR, Imaizumi N, Nunes RJ, Rino J, Kuonen F, Carvalho LM, Rüegg C, Grillo I, Barata J, Mareel M, Santos S (2010) Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis. PLoS ONE https://doi.org/10.1371/journal.pone.0011222
Yarnold J (2009) Early and locally advanced breast cancer: diagnosis and treatment National Institute for Health and Clinical Excellence guideline 2009. Clin Oncol 21(3):159–160. https://doi.org/10.1016/j.clon.2008.12.008
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241. https://doi.org/10.1056/NEJMoa022152
Siva S, Lobachevsky P, MacManus MP, Kron T, Mo ller A, Lobb RJ, Ventura J, Best N, Smith J, Ball D, Martin OA (2016) Radiotherapy for non-small cell lung cancer induces DNA damage response in both irradiated and out-of-field normal tissues. Clin Cancer Res 22(19):4817–4826. https://doi.org/10.1158/1078-0432.ccr-16-0138
Kaminski JM, Shinohara E, Summers J, Niermann KJ, Morimoto A, Brousal J (2005) The controversial abscopal effect. Cancer Treat Rev 31(3):159–172. https://doi.org/10.1016/j.ctrv.2005.03.004
Siva S, MacManus MP, Martin RF, Martin OA (2015) Abscopal effects of radiation therapy: A clinical review for the radiobiologist. Cancer Lett 356(1):82–90. https://doi.org/10.1016/j.canlet.2013.09.018
Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O’Reilly MS (2001) Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61(5):2207–2211
Redon CE, Dickey JS, Nakamura AJ, Kareva IG, Naf D, Nowsheen S, Kryston TB, Bonner WM, Georgakilas AG, Sedelnikova OA (2010) Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc Nat Acad Sci USA 107 (42):17992–17997. https://doi.org/10.1073/pnas.1008260107
Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML, Arteaga CL (2007) Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Investig 117(5):1305–1313. https://doi.org/10.1172/jci30740
Wu Y, Muldoon LL, Dickey D, Lewin SJ, Varallyay CG, Neuwelt EA (2009) Cyclophosphamide enhances human tumor growth in nude rat xenografted tumor models. Neoplasia 11(2):187–195. https://doi.org/10.1593/neo.81352
Yamauchi K, Yang M, Hayashi K, Jiang P, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM (2008) Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Can Res 68(2):516–520. https://doi.org/10.1158/0008-5472.can-07-3063
Demaria S, Golden EB, Formenti SC (2015) Role of local radiation therapy in cancer immunotherapy. JAMA Oncol 1(9):1325–1332. https://doi.org/10.1001/jamaoncol.2015.2756
Sprung CN, Forrester HB, Siva S, Martin OA (2015) Immunological markers that predict radiation toxicity. Cancer Lett 368(2):191–197. https://doi.org/10.1016/j.canlet.2015.01.045
Matsunaga A, Ueda Y, Yamada S, Harada Y, Shimada H, Hasegawa M, Tsujii H, Ochiai T, Yonemitsu Y (2010) Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma. Cancer 116(15):3740–3748. https://doi.org/10.1002/cncr.25134
Durante M, Brenner DJ, Formenti SC (2016) Does heavy ion therapy work through the immune system? Int J Radiat Oncol Biol Phys 96(5):934–936. https://doi.org/10.1016/j.ijrobp.2016.08.037
Gameiro SR, Malamas AS, Bernstein MB, Tsang KY, Vassantachart A, Sahoo N, Tailor R, Pidikiti R, Guha CP, Hahn SM, Krishnan S, Hodge JW (2016) Tumor cells surviving exposure to proton or photon radiation share a common immunogenic modulation signature, rendering them more sensitive to T cell–mediated killing. Int J Radiat Oncol Biol Phys 95(1):120–130. https://doi.org/10.1016/j.ijrobp.2016.02.022
Song CW, Kim M-S, Cho CL, Dusenbery K, Sperduto PW (2014) Radiobiological basis of SBRT and SRS. Int J Clin Oncol 19(4):570–578. https://doi.org/10.1007/s10147-014-0717-z
Kim RK, Cui YH, Yoo KC, Kim IG, Lee M, Choi Y, Suh Y, Lee SJ (2015) Radiation promotes malignant phenotypes through SRC in breast cancer cells. Cancer Sci 106(1):78–85. https://doi.org/10.1111/cas.12574
Rofstad EK, Mathiesen B, Galappathi K (2004) Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 64(1):13–18
Chung Y-L, Jian J, Cheng S, Tsai S, Chuang VP, Soong T, Lin Y-M, Horng C-F (2006) Sublethal irradiation induces vascular endothelial growth factor and promotes growth of hepatoma cells: implications for radiotherapy of hepatocellular carcinoma. Clin Cancer Res 12(9):2706–2715. https://doi.org/10.1158/1078-0432.CCR-05-2721
Feys L, Descamps B, Vanhove C, Vral A, Veldeman L, Vermeulen S, De Wagter C, Bracke M, De Wever O (2015) Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling. Oncotarget 6(29):26615–26632. https://doi.org/10.18632/oncotarget.5666
Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820–827. https://doi.org/10.1038/nature04186
Ohuchida K, Mizumoto K, Murakami M, Qian L-W, Sato N, Nagai E, Matsumoto K, Nakamura T, Tanaka M (2004) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Can Res 64(9):3215–3222. https://doi.org/10.1158/0008-5472.CAN-03-2464
Paquette B, Baptiste C, Therriault H, Arguin G, Plouffe B, Lemay R (2007) In vitro irradiation of basement membrane enhances the invasiveness of breast cancer cells. Br J Cancer 97(11):1505–1512. https://doi.org/10.1038/sj.bjc.6604072
Vilalta M, Rafat M, Giaccia AJ, Graves EE (2014) Recruitment of circulating breast cancer cells is stimulated by radiotherapy. Cell Rep 8(2):402–409. https://doi.org/10.1016/j.celrep.2014.06.011
Leroi N, Lallemand F, Coucke P, Noel A, Martinive P (2016) Impacts of ionizing radiation on the different compartments of the tumor microenvironment. Front Pharmacol 7:78. https://doi.org/10.3389/fphar.2016.00078
Takahashi Y, Teshima T, Kawaguchi N, Hamada Y, Mori S, Madachi A, Ikeda S, Mizuno H, Ogata T, Nojima K, Furusawa Y, Matsuura N (2003) Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res 63(14):4253–4257
Girdhani S, Lamont C, Hahnfeldt P, Abdollahi A, Hlatky L (2012) Proton irradiation suppresses angiogenic genes and impairs cell invasion and tumor growth. Radiat Res. https://doi.org/10.1667/RR2724.1
Baskar R, Dai J, Wenlong N, Yeo R, Yeoh K-W (2014) Biological response of cancer cells to radiation treatment. Front Mol Biosci 1:24. https://doi.org/10.3389/fmolb.2014.00024
Martin OA, Yin X, Forrester HB, Sprung CN, Martin RF (2016) Potential strategies to ameliorate risk of radiotherapy-induced second malignant neoplasms. Semin Cancer Biol 37:65–76. https://doi.org/10.1016/j.semcancer.2015.12.003
McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S, Lynam-Lennon N, Barsoom SH, Bowman KJ, Marples B, Jones GDD, Marignol L (2016) Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep 6(1):34796. https://doi.org/10.1038/srep34796
Pisco AO, Huang S (2015) Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘what does not kill me strengthens me’. Br J Cancer 112(11):1725–1732. https://doi.org/10.1038/bjc.2015.146
Gong C, Gu R, Jin H, Sun Y, Li Z, Chen J, Wu G (2016) Lysyl oxidase mediates hypoxia-induced radioresistance in non-small cell lung cancer A549 cells. Exp Biol Med 241(4):387–395. https://doi.org/10.1177/1535370215609694
Seo H, Bae S, Lee YS (2009) Radiation-induced cathepsin S is involved in radioresistance. Int J Cancer 124(8):1794–1801. https://doi.org/10.1002/ijc.24095
Tsutsumi K, Tsuda M, Yazawa N, Nakamura H, Ishihara S, Haga H, Yasuda M, Yamazaki R, Shirato H, Kawaguchi H, Nishioka T, Ohba Y (2009) Increased motility and invasiveness in tumor cells that survive 10 Gy irradiation. Cell Struct Funct 34(2):89–96. https://doi.org/10.1247/csf.09006
Kamlah F, Hänze J, Arenz A, Seay U, Hasan D, Juricko J, Bischoff B, Gottschald OR, Fournier C, Taucher-Scholz G, Scholz M, Seeger W, Engenhart-Cabillic R, Rose F (2011) Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells. Int J Radiat Oncol Biol Phys 80(5):1541–1549. https://doi.org/10.1016/j.ijrobp.2011.03.033
Fujita M, Yamada S, Imai T (2015) Irradiation induces diverse changes in invasive potential in cancer cell lines. Semin Cancer Biol 35:45–52. https://doi.org/10.1016/j.semcancer.2015.09.003
Park C-M, Park M-J, Kwak H-J, Lee H-C, Kim M-S, Lee S-H, Park I-C, Rhee C, Hong S-I (2006) Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor–mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Can Res 66(17):8511–8519. https://doi.org/10.1158/0008-5472.can-05-4340
Huguenin P, Beer KT, Allal A, Rufibach K, Friedli C, Davis JB, Pestalozzi B, Schmid S, Thoni A, Ozsahin M, Bernier J, Topfer M, Kann R, Meier UR, Thum P, Bieri S, Notter M, Lombriser N, Glanzmann C (2004) Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 22(23):4665–4673. https://doi.org/10.1200/JCO.2004.12.193
Bentzen J, Toustrup K, Eriksen JG, Primdahl H, Andersen LJ, Overgaard J (2015) Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol 54(7):1001–1007. https://doi.org/10.3109/0284186X.2014.992547
Chemoradiotherapy for Cervical Cancer Meta-Analysis C (2008) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26 (35):5802–5812. https://doi.org/10.1200/JCO.2008.16.4368
Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61(6):2744–2750
Qian L-W, Mizumoto K, Urashima T, Nagai E, Maehara N, Sato N, Nakajima M, Tanaka M (2002) Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 8(4):1223–1227
Moncharmont C, Levy A, Guy J-B, Falk AT, Guilbert M, Trone J-C, Alphonse G, Gilormini M, Ardail D, Toillon R-A, Rodriguez-Lafrasse C, Magné N (2014) Radiation-enhanced cell migration/invasion process: a review. Crit Rev Oncol 92(2):133–142. https://doi.org/10.1016/j.critrevonc.2014.05.006
Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Kawaguchi A, Suzumoto Y, Nojima K, Furusawa Y, Matsuura N (2005) Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 65(1):113–120
Rieken S, Habermehl D, Wuerth L, Brons S, Mohr A, Lindel K, Weber K, Haberer T, Debus J, Combs SE (2012) Carbon ion irradiation inhibits glioma cell migration through downregulation of integrin expression. Int J Radiat Oncol Biol Phys 83(1):394–399. https://doi.org/10.1016/j.ijrobp.2011.06.2004
Akino Y, Teshima T, Kihara A, Kodera-Suzumoto Y, Inaoka M, Higashiyama S, Furusawa Y, Matsuura N (2009) Carbon-ion beam irradiation effectively suppresses migration and invasion of human non–small-cell lung cancer cells. Int J Radiat Oncol Biol Phys 75(2):475–481. https://doi.org/10.1016/j.ijrobp.2008.12.090
Oweida A, Sharifi Z, Halabi H, Xu Y, Sabri S, Abdulkarim B (2016) Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells. Cancer Biol Ther 17(4):390–399. https://doi.org/10.1080/15384047.2016.1139241
Rieken S, Rieber J, Brons S, Habermehl D, Rief H, Orschiedt L, Lindel K, Weber KJ, Debus J, Combs SE (2015) Radiation-induced motility alterations in medulloblastoma cells. J Radiat Res 56(3):430–436. https://doi.org/10.1093/jrr/rru120
Narang H, Kumar A, Bhat N, Pandey BN, Ghosh A (2015) Effect of proton and gamma irradiation on human lung carcinoma cells: Gene expression, cell cycle, cell death, epithelial–mesenchymal transition and cancer-stem cell trait as biological end points. Mutat Res 780:35–46. https://doi.org/10.1016/j.mrfmmm.2015.07.006
Zheng Q, Liu Y, Zhou HJ, Du YT, Zhang BP, Zhang J, Miao GY, Liu B, Zhang H (2015) X-ray radiation promotes the metastatic potential of tongue squamous cell carcinoma cells via modulation of biomechanical and cytoskeletal properties. Human Exp Toxicol 34(9):894–903. https://doi.org/10.1177/0960327114561664
Ishihara S, Yasuda M, Nishioka T, Mizutani T, Kawabata K, Shirato H, Haga H (2013) Irradiation-tolerant lung cancer cells acquire invasive ability dependent on dephosphorylation of the myosin regulatory light chain. FEBS Lett 587(6):732–736. https://doi.org/10.1016/j.febslet.2013.01.055
Lee S, Cheng H, Yuan Y, Wu S (2014) Regulation of ionizing radiation-induced adhesion of breast cancer cells to fibronectin by Alpha5beta1 integrin. Radiat Res 181(6):650–658. https://doi.org/10.1667/RR13543.1
Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, Gabriele P, Comoglio PM, Boccaccio C (2011) Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. JNCI 103(8):645–661. https://doi.org/10.1093/jnci/djr093
Shen CJ, Sharma A, Vuong D-V, Erler JT, Pruschy M, Broggini-Tenzer A (2014) Ionizing radiation induces tumor cell lysyl oxidase secretion. BMC Cancer 14(1):1–10. https://doi.org/10.1186/1471-2407-14-532
Lee S, Jeong E, Ju M, Jeon H, Kim M, Kim C, Park H, Han S, Kang H (2016) Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer 16(1):10. https://doi.org/10.1186/s12943-016-0577-4
Gomez-Casal R, Bhattacharya C, Ganesh N, Bailey L, Basse P, Gibson M, Epperly M, Levina V (2013) Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes. Mol Cancer 12(1):1–13. https://doi.org/10.1186/1476-4598-12-94
Ghisolfi L, Keates AC, Hu X, Lee D-k, Li CJ (2012) Ionizing radiation induces stemness in cancer cells. PLoS ONE 7 (8). https://doi.org/10.1371/journal.pone.0043628
Brunner TB, Kunz-Schughart LA, Grosse-Gehling P, Baumann M (2012) Cancer stem cells as a predictive factor in radiotherapy. Sem Radiat Oncol 22(2):151–174. https://doi.org/10.1016/j.semradonc.2011.12.003
Jung J-W, Hwang S-Y, Hwang J-S, Oh E-S, Park S, Han I-O (2007) Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur J Cancer 43(7):1214–1224. https://doi.org/10.1016/j.ejca.2007.01.034
Bae J-H, Park S-H, Yang J, Yang K, Yi J (2015) Stem cell-like gene expression signature identified in ionizing radiation-treated cancer cells. Gene 572(2):285–291. https://doi.org/10.1016/j.gene.2015.08.005
Yuan W, Yuan Y, Zhang T, Wu S (2015) Role of Bmi-1 in regulation of ionizing irradiation-induced epithelial-mesenchymal transition and migration of breast cancer cells. PLoS ONE. https://doi.org/10.1371/journal.pone.0118799
Javaid S, Zhang J, Anderssen E, Black JC, Wittner BS, Tajima K, Ting DT, Smolen GA, Zubrowski M, Desai R, Maheswaran S, Ramaswamy S, Whetstine JR, Haber DA (2013) Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of snail-1. Cell Rep 5(6):1679–1689. https://doi.org/10.1016/j.celrep.2013.11.034
McDonald OG, Wu H, Timp W, Doi A, Feinberg AP (2011) Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol 18(8):867–874. https://doi.org/10.1038/nsmb.2084
Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y (2008) γH2AX and cancer. Nat Rev Cancer. https://doi.org/10.1038/nrc2523
Weyemi U, Redon CE, Choudhuri R, Aziz T, Maeda D, Boufraqech M, Parekh PR, Sethi TK, Kasoji M, Abrams N, Merchant A, Rajapakse VN, Bonner WM (2016) The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition. Nat Commun 7:10711. https://doi.org/10.1038/ncomms10711
Weyemi U, Redon CE, Sethi TK, Burrell AS, Jailwala P, Kasoji M, Abrams N, Merchant A, Bonner WM (2016) Twist1 and Slug mediate H2AX-regulated epithelial-mesenchymal transition in breast cells. Cell Cycle 15(18):2398–2404. https://doi.org/10.1080/15384101.2016.1198864
Weyemi U, Redon CE, Bonner WM (2016) H2AX and EMT: deciphering beyond DNA repair. Cell Cycle 15(10):1305–1306. https://doi.org/10.1080/15384101.2016.1160659
Park J, Jang S, Kang S, Park S, Hwang S-G, Kim W-J, Kang J, Um H-D (2012) Establishment of animal model for the analysis of cancer cell metastasis during radiotherapy. Radiat Oncol 7(1):1–11. https://doi.org/10.1186/1748-717X-7-153
Zhang H, Luo H, Jiang Z, Yue J, Hou Q, Xie R, Wu S (2016) Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma. J Radiat Res 57(4):370–380. https://doi.org/10.1093/jrr/rrw030
Meredith SL, Bryant JL, Babur M, Riddell PW, Behrouzi R, Williams KJ, White A (2016) Irradiation decreases the neuroendocrine biomarker pro-opiomelanocortin in small cell lung cancer cells in vitro and in vivo. PLOS ONE. https://doi.org/10.1371/journal.pone.0148404
Carl C, Flindt A, Hartmann J, Dahlke M, Rades D, Dunst J, Lehnert H, Gieseler F, Ungefroren H (2016) Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway. Cell Mol Life Sci 73(2):427–443. https://doi.org/10.1007/s00018-015-2003-2
Pan Y, Zhou C, Yuan D, Zhang J, Shao C (2016) Radiation exposure promotes hepatocarcinoma cell invasion through epithelial mesenchymal transition mediated by H2S/CSE pathway. Radiat Res 185(1):96–105. https://doi.org/10.1667/RR14177.1
Vilalta M, Rafat M, Graves EE (2016) Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci 73(16):2999–3007. https://doi.org/10.1007/s00018-016-2210-5
Eberle F, Saulich MF, Leinberger FH, Seeger W, Engenhart-Cabillic R, Dikomey E, Hänze J, Hattar K, Subtil F (2016) Cancer cell motility is affected through 3D cell culturing and SCF/c-Kit pathway but not by X-irradiation. Radiother Oncol 119(3):537–543. https://doi.org/10.1016/j.radonc.2016.04.036
Das A, McDonald D, Lowe S, Bredlau A-L, Vanek K, Patel SJ, Cheshier S, Eskandari R (2016) Immunological low-dose radiation modulates the pediatric medulloblastoma antigens and enhances antibody-dependent cellular cytotoxicity. Child’s Nerv Syst 33(3):429–436. https://doi.org/10.1007/s00381-016-3305-x
Roth B, Gibhardt CS, Becker P, Gebhardt M, Knoop J, Fournier C, Moroni A, Thiel G (2015) Low-dose photon irradiation alters cell differentiation via activation of hIK channels. Pflügers Archiv 467(8):1835–1849. https://doi.org/10.1007/s00424-014-1601-4
Weichselbaum RR, Liang H, Deng L, Fu YX (2017) Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol 14(6):365–379. https://doi.org/10.1038/nrclinonc.2016.211
Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu YX (2014) Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin investig 124(2):687–695. https://doi.org/10.1172/JCI67313
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Bourhaba M, Quantin X, Tokito T, Mekhail T, Planchard D, Kim YC, Karapetis CS, Hiret S, Ostoros G, Kubota K, Gray JE, Paz-Ares L, de Castro Carpeno J, Wadsworth C, Melillo G, Jiang H, Huang Y, Dennis PA, Ozguroglu M, Investigators P (2017) Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med. https://doi.org/10.1056/NEJMoa1709937
Formenti SC, Demaria S (2013) Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 105(4):256–265. https://doi.org/10.1093/jnci/djs629
Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H, Enderling H (2017) Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Res 19(1):75. https://doi.org/10.1186/s13058-017-0870-1
Choi JW, Kim JK, Yang YJ, Kim P, Yoon KH, Yun SH (2015) Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells. Cancer Res 75(21):4474–4482. https://doi.org/10.1158/0008-5472.CAN-15-0684
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3(6):453–458. https://doi.org/10.1038/nrc1098
Giancotti FG (2013) Mechanisms governing metastatic dormancy and reactivation. Cell 155(4):750–764. https://doi.org/10.1016/j.cell.2013.10.029
Acknowledgements
We would like to acknowledge the assistance of Ms Diane Russo in preparation of the manuscript. This work was supported by a grant from the Australian National Health and Medical Research Council (NHMRC #1104139).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Blyth, B.J., Cole, A.J., MacManus, M.P. et al. Radiation therapy-induced metastasis: radiobiology and clinical implications. Clin Exp Metastasis 35, 223–236 (2018). https://doi.org/10.1007/s10585-017-9867-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-017-9867-5